These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6448529)

  • 1. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Lehmann W; Samtleben R; Graetz H; Langen P
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
    Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
    Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Böhmer FD; Lehmann W; Schmidt HE; Langen P; Grosse R
    Exp Cell Res; 1984 Feb; 150(2):466-76. PubMed ID: 6363109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of chalone action.
    Lehmann W; Graetz H; Schunck H; Schütt M; Langen P
    Acta Histochem Suppl; 1983; 27():63-71. PubMed ID: 6223337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ehrlich ascites cell (EAC) chalone assay using purified calf thymus-DNA polymerase alpha.
    Nakai GS; Gergely H
    Biomedicine; 1980 Nov; 33(7):208-9. PubMed ID: 6452912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis.
    Bielka H; Grosse R; Böhmer F; Junghahn I; Binas B
    Biomed Biochim Acta; 1986; 45(4):441-5. PubMed ID: 3707560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between the mitosis-inhibitory activity of a chalone preparation of Ehrlich ascites tumor and its diurnal secretion].
    Bogoeva MV; Antokhin AI; Romanov IuA
    Biull Eksp Biol Med; 1981 Mar; 91(3):343-5. PubMed ID: 6454450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of different fractions obtained by gel filtration of a chalone-containing preparation from Ehrlich ascites tumor on mitotic activity and DNA synthesis in this tumor].
    Matsak NIa; Antokhin AI; Romanov IuA
    Biull Eksp Biol Med; 1988 Aug; 106(8):202-4. PubMed ID: 2970870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of membrane-associated growth inhibitor activity for Ehrlich ascites mammary carcinoma cells.
    Herrmann I; Grosse R
    Biomed Biochim Acta; 1986; 45(4):447-57. PubMed ID: 3010958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of adrenaline on the mitosis-inhibiting action of a chalone-containing preparation in Ehrlich ascites tumor].
    Romanov IuA; Ivchenko TN; Sultanova ZF
    Biull Eksp Biol Med; 1988 Mar; 105(3):345-7. PubMed ID: 2964881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered growth control by natural growth inhibitors in the mutant HD33 substrain of the Ehrlich-Lettré ascites mammary carcinoma.
    Lehmann W; Böhmer FD; Karsten U; Graetz H; Koberling A; Kunde D; Langen P
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):69-74. PubMed ID: 3595686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell division and changes of the duration of mitosis in murine Ehrlich ascites carcinoma after a single administration of chalone-containing extract from this tumor].
    Romanov IuA; Semenova MV
    Biull Eksp Biol Med; 1982 Mar; 93(3):81-3. PubMed ID: 6212091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of transforming growth factor activity in mammary epithelial tissues.
    Eckert K; Lübbe L; Schön R; Grosse R
    Biochem Int; 1985 Oct; 11(4):441-51. PubMed ID: 3878713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
    Ghosh S; Roy S; Banerjee M; Maity P
    J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.